# Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608

> **NCT01703858** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 113608 PIB
- **DRUG:** BI 113608
- **DRUG:** BI 113608
- **DRUG:** BI 113608
- **DRUG:** pantoprazole 40 mg STADA
- **DRUG:** BI 113608

## Key facts

- **NCT ID:** NCT01703858
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703858, "Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01703858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*